ChainCatcher news, according to Businesswire, Nasdaq-listed company ENDRA Life Sciences announced that it has signed a securities purchase agreement, under which investors have agreed to subscribe for 744,340 shares of common stock and accompanying warrants to purchase up to 1,488,680 shares of common stock. If all warrants are exercised, the company will raise $144 millions to support its digital asset treasury. ENDRA Life Sciences previously disclosed that it would implement a bitcoin-based revenue generation strategy.